DrugPatentWatch Database Preview

Litigation for DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

« Back to Dashboard

US Court Litigation for DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
6,414,126	AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc.		2018-05-01		35:271 Patent Infringement	District Court, D. Delaware	None
6,414,126	MITSUBISHI TANABE PHARMA CORPORATION v. AUROBINDO PHARMA USA, INC.		2017-07-07		15:1126 Patent Infringement	District Court, D. New Jersey	None
6,414,126			2018-01-09		15:1126 Patent Infringement	District Court, D. New Jersey	None
6,515,117	AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc.		2018-05-01		35:271 Patent Infringement	District Court, D. Delaware	None
6,515,117	MITSUBISHI TANABE PHARMA CORPORATION v. AUROBINDO PHARMA USA, INC.		2017-07-07		15:1126 Patent Infringement	District Court, D. New Jersey	None
6,515,117			2018-01-09		15:1126 Patent Infringement	District Court, D. New Jersey	None

Patent Trial and Appeal Board Cases for DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
RE44,186	Mylan Pharmaceuticals Inc.		2015-06-04	2015-06-04	AstraZeneca AB	Inter partes review		2016-05-02	Jeffrey Robl
RE44,186	Wockhardt Bio AG		2016-05-11	2016-05-11	AstraZeneca AB	Inter partes review		2016-08-23	Jeffrey Robl
RE44,186	Amneal Pharmaceuticals LLC		2016-06-01	2016-06-03	AstraZeneca AB	Inter partes review		2016-11-22	Jeffrey Robl
RE44,186	Aurobindo Pharma U.S.A., Inc.		2016-06-02	2016-06-02	ASTRAZENECA AB	Inter partes review		2016-10-21	Jeffrey Robl
RE44,186	Teva Pharmaceuticals USA Inc.		2016-06-01	2016-06-01	AstraZeneca AB	Inter partes review		2016-09-23	Jeffrey Robl